drugset / Trial / NCT03244592

Minocycline for Alcohol Use Disorder

NCT03244592

RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this proposal is to advance medication development for alcohol use disorder by examining the efficacy and mechanisms of action of minocycline, a neuroimmune modulator, as a potential treatment. This study has important clinical implications, as the available treatments for alcohol use disorder are only modestly effective and testing novel medications is a high research priority.

Timeline

Start
2018-01-15
Primary completion
2018-03-01
Completion
2018-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minocycline Small molecule 200 mg